Visiting Scientist Fellow - Regulatory (FDE)

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 73,000 - 99,000; Full time

Benefits offered by this job

401(k) plan

Pension

Medical benefits

Well-being benefits

Job summary

Lilly in Indianapolis invites applications for a Visiting Scientist – Fixed Duration Employee. The one-year fellowship introduces you to medical, commercial, clinical development, project management, health outcomes, and regulatory aspects of drug development, with continuous contact across functions.

Interviews begin October 2026 with anticipated start date in June or July 2027. Compensation includes $86,000 annual base, potential bonus, and comprehensive benefits.

Qualifications

• PharmD/MD/DO or PhD with Master’s degree required.
• Degree completed by June 2027 but not earlier than 2024.
• Authorized to work in the United States on a full‑time basis.

Skills

Interpersonal communication

Leadership

Critical thinking

Learning agility

AI tools experience

Education

PharmD/MD/DO or PhD with Master’s

Tools

Generative AI platforms

AI research tools

Job description

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Visiting Scientist - Fixed Duration Employee

The Visiting Scientist Fellowship is a one-year postgraduate program that introduces participants to various medical, commercial, clinical development, project management, health outcomes, and regulatory aspects of the pharmaceutical industry. It is designed to train professionals for a career in the pharmaceutical industry by allowing them hands‑on experience with the drug development process. The visiting scientist fellow is assigned to one department yet has continuous contact with other functional areas.

Interviews for these positions will begin in October 2026 with an anticipated start date in June or July of 2027.

Positions

• Global Regulatory Policy & Strategy (GRPS)
• Global Medicines Quality
• Global Regulatory Strategy
• Global Labeling

Visiting Scientist | Lilly

Basic Qualifications

• PharmD, MD/DO, relevant PhD and/or Master’s degree
• Completion of required degree by June 2027 but not earlier than 2024
• Qualified applicants must be authorized to work in the United States on a full‑time basis.
• Lilly will not provide support for or sponsor work authorization or visas for this role, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1.

Additional Skills/Preferences

• Strong interpersonal and communication skills
• Strong leadership, decision‑making, and critical thinking skills
• A demonstrated ability to learn quickly
• Prior experience using AI tools (e.g., generative AI platforms, automation tools, or AI‑assisted research/analytics tools) in an academic, project, or work setting.
• As part of Lilly’s commitment to innovation, interns will have the opportunity to build fluency with AI tools used across the business. We expect interns to approach these tools with curiosity, apply critical thinking to AI‑assisted work, and always prioritize accuracy, confidentiality, and ethical standards in how they use them.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees.

Current groups include:

• Africa
• Middle East
• Central Asia (AMECA)
• Black Employees at Lilly (BE@Lilly)
• Chinese Culture Network (CCN)
• EnAble
• Evolve
• Lilly Indian Network (LIN)
• Organization of Latinx at Lilly (OLA)
• Pride (LGBTQ+ Allies)
• Veterans Leadership Network (VLN)
• Women’s Initiative for Leading at Lilly (WILL)

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $86,000 Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance).

In addition, Lilly offers a comprehensive benefit program to eligible employees, including

• eligibility to participate in a company‑sponsored 401(k)
• pension
• vacation benefits
• eligibility for medical, dental, vision and prescription drug benefits
• flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
• life insurance and death benefits
• certain time off and leave of absence benefits
• and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)

Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly At Lilly we strive to ensure our employees are part of a team that cares about them and our shared purpose of making life better for those around the world.

How do we do this?

We continue to look for ways to include, innovate, accelerate and deliver while maintaining integrity, excellence and respect for people.

We hope that you seek to join us on our journey as we create medicine and deliver improved outcomes for patients across the globe! #WeAreLilly